Lineage Cell Therapeutics, Inc.

NYSE

LCTX

Stock

Yield per half year: +14.15%
Dividend yield: 0%
Sector: Healthcare

Forward indicators

Parameter	Grade	Value	Sector average	Difference with sector, %	Average for 5 years	Difference from average, %
P/E	0/10	-12.8	52.65	-124.31%	-10.26	24.73%
P/E Forward		-13.8
P/S		25.08	4.03	522.53%
P/S Forward		23.53
P/BV		41.79	10.86	284.96%
P/BV Forward		72.39
Ev/Ebitda		-2.61	16.78	-115.54%
Ev/Ebitda Forward		-2.56